NAIROBI, Kenya – The Pharmacy and Poisons Board  plays a pivotal role in ensuring patients have access to high-quality, safe, and effective medical products and technologies.

During the World Patient Safety Day walk at PPB today, Dr. Obadiah Naikuni, Director of Quality Control, speaking on behalf of Dr. F. M. Siyoi, the Chief Executive Officer of PPB, emphasized the paramount importance of patient safety within the healthcare sector. Dr. Siyoi underscored the necessity of safeguarding patients from harm, medication errors, and infections.

He reaffirmed PPB’s unwavering commitment to maintaining continuous surveillance activities designed to ensure the safety of medical products in the market.

“We strongly encourage patients and healthcare professionals to proactively report any adverse events through the Pharmacovigilance initiative. This reporting process is facilitated by the Pharmacovigilance Electronic Reporting System (PvERS), which is easily accessible via mobile phones,” he advised.

Dr. Siyoi also called for collective efforts among all healthcare stakeholders to fortify patient safety. “We advocate for a joint endeavor in creating healthcare systems where every patient can trust that their well-being remains our topmost priority,” he stated.

.